post-graduate

faculty

centre of excellence

Course Director :

Dr Jean-Marie BOEYNAEMS

Programme Board of Studies :

Dr Jean-Marie BOEYNAEMS
Dr Marc de LONGUEVILLE
Dr Daniel BRASSEUR
Dr Guy VANDENHOVEN
Dr Christian MELOT

Education Quality Assessment Board :

Dr Jean-Marie BOEYNAEMS
Dr Dominique DUBOIS
Mrs Bahija JELLOULI

Center Quality Officer :

Dr Dominique DUBOIS

Board of Directors :

Dr André HERCHUELZ, chairman
Dr Dominique DUBOIS, vice-chairman
Dr Jean-Marie BOEYNAEMS, secretary-treasurer

Lecturers :

Franck ATIENZAR, Ph.D., Associate Director, UCB BioPharma SPRL

Enrico BASTIANELLI, M.D., MBA, Chief Executive Officer Bone Therapeutics

William BIRD, Ph.D., European, British and German Patent Attorney, Patentive

Jean-Marie BOEYNAEMS, M.D, Ph.D. in biochemistry and pharmacology. Professor of pharmacology, ULB

Daniel BRASSEUR, M.D, paediatrician at the Brussels University Children's Hospital, Queen Fabiola and currently chair of the paediatric committee (PDCO) at the European Medicines Agency (EMA) in London

Stéphane CALLEWAERT, M.Sc., Molecular Biology, ULB, Manager Regulatory Policy, Worldwide Regulatory Affairs, GSK Vaccines

Isabelle CAMPINE, M.D., Director Regulatory Affairs, UCB Pharma, Brussels

Gil CARRASQUINHO, M.D., Head of Medical Affairs Europe, Global Medical Affairs, Santen, Switzerland

Marc CEUPPENS, M.D., MBCPM, KUL, Therapeutic Area Safety Head Infectious diseases and Vaccines, Janssen Infectious Diseases

Aurore COLOMAR, Ph.D. in Biological and Medical Sciences, Professor of neuropharmacology, Université de Mons, Mons, Belgium

Augustin COPPEE, Graduate in "Healthcare Management, Economics and Policy", SDA Bocconi, Milano. Coordinator of the "Medical Devices Plan" at the Federal Agency for Medicines and Health Products, Brussels

Marc CZARKA, M.D., MBCPM, Member of the board of BeAPP, Managing Partner HM3A (Market Access Associates)

Marc de LONGUEVILLE, MD, PhD, FFPM, MBPCM, Sr Medical Director Immunology Safety and registries, UCB BioPharma SPRL

Viviane De MAERTELAER, Ph.D. in physics, ULB, Professor of Biostatistics at the ULB

Christian de MEY, M.D., FFPM, FRCP, Associat. Prof. University of Frankfurt, Clinical pharmacologist ACPS, Mainz-Kastel, Germany

Philippe DETILLEUX, DVM Université de Liège, Ph.D. in veterinary pathology, Iowa State University, Head Drug Safety Evaluation, Sanofi, France

Alain DE WEVER, M.D., Internist, Graduate in Hospital Management, ULB , Professor at the ULB, Director DWHCC Belgium

Stephane DHALLUIN, PharmD, PhD, ERT, DABT, Director, Head of Alliance Management Practice,UCB Biopharma Sprl

Dominique DUBOIS, M.D., KUL, FFPM, FBCPM. Lecturer in Health Economics ULB and Principal Consultant, Patient Value Solutions (PVS) Consultancy, Belgium. Editor-in-chief of Frontiers in Pharmacoeconomics and health Outcomes

Christian DUBY, MS, M.D., Clinical Operations Director, PFIZER Clinical Research Unit, Brussels

François DUFRASNE, Ph.D. in pharmacy ULB, Professor at the Institute of Pharmacy of ULB and UMH

Caroline DUMAS, M.D., MSc, Medical Executive, Vigilex, Rotterdam, Netherlands

Alain DUPONT, M.D., Ph.D. in Pharmacology V.U.B., Head Clinical Pharmacology & Pharmacotherapy UZ Brussel. Professor of Pharmacology and therapeutics, V.U.B. Dean of Medical School, V.U.B.

Vincent DUPRIEZ, Ph.D. in Agronomical sciences, UCL, Senior Scientist, Perkin-Elmer Life Sciences, Zaventem, Belgium

Rachel EMERSON, Independent Consultant

Alan FAUCONNIER, M.Sc., M.D., Federal Agency for Medicines and Health Products, Brussels

Yves GEYSELS, Ph.D., Chair of the Association of Clinical Research Professionals (ACRP), Director Clinical Operations, Quintiles, Brussels

Michel GILLARD, Ph.D. in Applied Medical Biology, ULB, Head of Cellular and Molecular Biology, CNS Research, UCB Pharma, Braine L'Alleud, Belgium

Michel GOLDMAN, M.D., PhD, ULB, Director of the Institute for Interdisciplinary Innovation in Healthcare

Jonathan GOOLE, Ph.D. in Pharmacy, ULB, Junior Lecturer. Laboratory of Pharmaceutics and Biopharmaceutics, Faculty of Pharmacy

Ludo HAAZEN, M.D., Freelance Medical and Clinical consultant, Qualified Person for Pharmacovigilance and regulatory Clinical Expert

Anne HEPBURN, Ph.D. in Medical Biology, ULB, Director scientific writing and regulatory affairs, 4Clinics Belgium

André HERCHUELZ, M.D., Ph.D., Professor at the ULB, Member of the Belgian Medicines Commission, former Chairman of the Ethics Committee of Erasme Hospital

Johan HEYLEN, Pharmacist KUL, Chief Commercial Officer, Ablynx nv

Dipak KALRA, President of the EuroRec Institute, president of of i~H, Professor of Health Informatics, UCL, Visitng professor, University of Gent

Ingrid KLINGMANN, MD, PhD, FFPM, FBCPM, Managing Director, Pharmaplex bvba, Chairman of EFGCP's Board

Denis LACOMBE, M.D., M.Sc., European Organisation for Research and Treatment of Cancer (EORTC), Brussels

Anne LENAERS, Pharmacist, Division Research & Development Federal Agency for Medicines and Health Products, Brussels

André LHOIR, M.D., Medical Assessor, Federal Agency for Medicines and Heath Products, Belgium, Member of the Committee for Orphan Medicinal Products (COMP) of EMA

Clarisse LUKUAMUSU, Pharmacist, Pfizer, Clinical Research Unit, Brussels

Hugues MALONNE, Ph.D. in pharmaceutical sciences, ULB, Professor at ULB, Managing partner HHC Partners, Alpine Partners AG,Switzerland, non executive board member, Luxembourg Institute of Health, Luxembourg

Christian MELOT, M.D., Ph.D., ULB, M. Sci. Biostatistics, Limburgs Universitair Centrum, Professor of Biostatistics at ULB, Professor, Head of the Emergency Department, Erasme Hospital

Françoise MEUNIER, M.D., Ph.D., ULB, FRCP, FFPM, General Director of the European Organisation for Research and Treatment of Cancer (EORTC), Brussels

Flora MUSUAMBA TSHINANU, Pharmacist, Master in pharmacy and biomedical sciences & Ph.D. in pharmacy, UCL (Université Catholique de Louvain), Research asociate, UCL (University College London)

Monique PODOOR, M.D., Dip. Pharm. Med., Head of PHARMAKON, Luxembourg, Chairperson of BeAPP

Karin REYGAERT, Pharmacist, Associate Director GQRC CT&C, Bristol-Myers Squibb

Pascal RYCKMANS, Director of operations, Pfizer Clinical Research Unit, Brussels

Michèle SANGELEER, M.D., ULB, Medical Affairs Manager, Eli Lilly Benelux

Mathias SCHIFFLERS, M.B., UCL, DPM & MBA (ULB), Director, Medical Affairs, Developed Markets, Brussels

Eckart W.SCHWARZ, M.B., Ch.B., University of Bristol, Vice President & Global head of Worldwide Regulatory Compliance, GSK, Philadelphia, USA

Romain SEFFER, Partner at PwC-Belgian Pharmaceuticals and Life Sciences Leader

Franck STRUYF, M.D., Ph.D. Director, Clinical and Epidemiology R & D Project Lead HPV and hepatitis vaccines GSK Biologicals

Luc TRITSMANS, M.D., FBCPM, Senior Director, Compound Development Team Leader, Early Developments CNS, Janssen R&D, Janssen Pharmaceutica, Belgium

Luc VAN BORTEL, M.D., Ph.D., Head of Drug Research Unit Ghent (D.R.U.G.), the Phase I-II Unit of Ghent University Hospital, Belgium, Professor of Clinical Pharmacology and Therapeutics, Faculty of Medicine and Health Sciences, Ghent University, Belgium

Jean-Pierre VALENTIN, Ph.D. in Physiology & Pharmacology, University of Montpellier, Senior Director Head of Investigative Toxicology, UCB Pharma, Braine-l’Alleud, Belgium

Guy VANDENHOVEN, M.D., KUL, Ph.D., FFPM, FBCPM, HEPHS-ISEK, Environmental, Ageing & Occupational Physiology Laboratory

Dirk VANDER MIJNSBRUGGE, M.D., KUL, MBA, Medical Director European Mid Sized Markets, Pfizer Specialty Care Business Unit

Robert VANDER STICHELE, M.D., RUG and VUB, Senior Researcher, Health Technology Assessment, Heymans Institute of Pharmacology and Belgian Health Care Council

Dirk VERHOEVEN, Business - Learning & Development - Manager North European Region ZOETIS

René VERLOES, M.D., Ph.D., lecturer in preclinical safety of medicines VUB, Senior Director Clinical Pharmacology & Early Development Team Leader, Janssen Infectious Diseases – Diagnostics BVBA

Els VERSCHAEREN, Pharmacist and hospital pharmacist, KUL, Federal Agency for Medicines and Health Products, Belgium.

Bernard VRIJENS, Ph.D., Chief Scientist, AARDEX Group, MWV Company, Visé, Belgium, Adjunct professor, University of Liège, Belgium

Marah WAJSKOP, Associate Director, Clinical Project Management at UCB Pharma SA


Abbreviations : 
U.L.B. : Université Libre de Bruxelles 
V.U.B. : Vrij Universiteit Brussel 
U.C.L. : Université Catholique de Louvain 
K.U.L. : Katholiek Universiteit Leuven 
R.U.G. : Rijksuniversiteit Gent .